{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:11:03Z","timestamp":1782364263037,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JC-YBQN-0965"],"award-info":[{"award-number":["2024JC-YBQN-0965"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","award":["2023-JC-QN-0831"],"award-info":[{"award-number":["2023-JC-QN-0831"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.eprac.2024.12.015","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T22:59:06Z","timestamp":1735167546000},"page":"465-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of Baseline Thyroid Stimulating Hormone With In-Hospital Outcomes in Patients With Atrial Fibrillation and Coronary Artery Diseases"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-7518","authenticated-orcid":false,"given":"Lisha","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxue","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eprac.2024.12.015_bib1","first-page":"50","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"70","author":"Kirchhof","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.015_bib2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.eprac.2024.12.015_bib3","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"9921","key":"10.1016\/j.eprac.2024.12.015_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta\u2013analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.015_bib5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.amjmed.2019.06.008","article-title":"Outcomes in newly diagnosed atrial fibrillation and history of acute coronary syndromes: insights from GARFIELD\u2013AF","volume":"132","author":"Verheugt","year":"2019","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.eprac.2024.12.015_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.015_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/thy.2010.0298","article-title":"Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all\u2013cause mortality independent of coronary heart disease risk factors: a PreCIS database study","volume":"21","author":"McQuade","year":"2011","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.015_bib8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"issue":"14","key":"10.1016\/j.eprac.2024.12.015_bib9","article-title":"High\u2013normal thyroid\u2013stimulating hormone shows a potential causal association with arrhythmia recurrence after catheter ablation of atrial fibrillation","volume":"7","author":"Morishima","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"19","key":"10.1016\/j.eprac.2024.12.015_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.015_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1161\/CIRCEP.113.000502","article-title":"Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats","volume":"6","author":"Zhang","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"22","key":"10.1016\/j.eprac.2024.12.015_bib12","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","article-title":"Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation","volume":"136","author":"Baumgartner","year":"2017","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.015_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12916-017-0777-9","article-title":"What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta\u2013analysis of 55 cohort studies involving 1,898,314 participants","volume":"15","author":"Ning","year":"2017","journal-title":"BMC Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.015_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-11-0299","article-title":"A\u00a0critical review and meta\u2013analysis of the association between overt hyperthyroidism and mortality","volume":"165","author":"Brandt","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.015_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"January","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.015_bib16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1084\/jem.20181473","article-title":"Thyrotropin aggravates atherosclerosis by promoting macrophage inflammation in plaques","volume":"216","author":"Yang","year":"2019","journal-title":"J\u00a0Exp Med"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.015_bib17","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI107014","article-title":"Inhibition of thyrotropin response to thyrotropin\u2013releasing hormone by small quantities of thyroid hormones","volume":"51","author":"Snyder","year":"1972","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.015_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jcem-70-2-453","article-title":"Applications of a new chemiluminometric thyrotropin assay to subnormal measurement","volume":"70","author":"Spencer","year":"1990","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2024.12.015_bib19","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1210\/jc.2012-4223","article-title":"The relationship between TSH and free T\u2084 in a large population is complex and nonlinear and differs by age and sex","volume":"98","author":"Hadlow","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.015_bib20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/en.2019-00055","article-title":"Arrestin\u2013\u03b2\u20131 physically scaffolds TSH and IGF1 receptors to enable crosstalk","volume":"160","author":"Krieger","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.eprac.2024.12.015_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.944715","article-title":"The mysterious universe of the TSH receptor","volume":"13","author":"Vieira","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 2","key":"10.1016\/j.eprac.2024.12.015_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.17.S2.1","article-title":"American association of clinical endocrinologists medical guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan","volume":"17","author":"Handelsman","year":"2011","journal-title":"Endocr Pract"},{"issue":"21","key":"10.1016\/j.eprac.2024.12.015_bib23","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","article-title":"Thyroid status, disability and cognitive function, and survival in old age","volume":"292","author":"Gussekloo","year":"2004","journal-title":"JAMA"},{"issue":"9285","key":"10.1016\/j.eprac.2024.12.015_bib24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all\u2013cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10\u2013year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.015_bib25","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2009-1625","article-title":"Serum thyroid\u2013stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long\u2013term thyroxine therapy","volume":"95","author":"Flynn","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.015_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0047-6374(86)90052-7","article-title":"Effects of chronic hyperthyroidism on the lifespan of the rat","volume":"33","author":"Ooka","year":"1986","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.015_bib27","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0047-6374(83)90104-5","article-title":"Pituitary\u2013thyroid activity and longevity in neonatally thyroxine\u2013treated rats","volume":"22","author":"Ooka","year":"1983","journal-title":"Mech Ageing Dev"},{"issue":"6 Suppl 2","key":"10.1016\/j.eprac.2024.12.015_bib28","first-page":"1583S","article-title":"Living fast, dying when? The link between aging and energetics","volume":"132","author":"Speakman","year":"2002","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.eprac.2024.12.015_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.674841","article-title":"Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: pooled individual results of two randomised controlled trials","volume":"12","author":"Zijlstra","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.015_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/cen.13472","article-title":"Thyroid\u2013stimulating hormone and risk of sudden cardiac death, total mortality and cardiovascular morbidity","volume":"88","author":"Lang\u00e9n","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.015_bib31","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.5114\/aoms.2016.63264","article-title":"High\u2013normal thyroid\u2013stimulating hormone in euthyroid subjects is associated with risk of mortality and composite disease endpoint only in women","volume":"14","author":"Altay","year":"2018","journal-title":"Arch Med Sci"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.015_bib32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/medicina55050175","article-title":"The effect of thyroid stimulating hormone level within the reference range on in\u2013hospital and short\u2013term prognosis in acute coronary syndrome patients","volume":"55","author":"G\u00fcrdo\u011fan","year":"2019","journal-title":"Medicina (Kaunas)"},{"issue":"10","key":"10.1016\/j.eprac.2024.12.015_bib33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/clc.23062","article-title":"Thyroid stimulating hormone elevation as a predictor of long\u2013term mortality in patients with acute myocardial infarction","volume":"41","author":"Seo","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.eprac.2024.12.015_bib34","article-title":"Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study","volume":"366","author":"Thayakaran","year":"2019","journal-title":"BMJ"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:42:14Z","timestamp":1744717334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24008747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1530891X24008747"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.12.015","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Baseline Thyroid Stimulating Hormone With In-Hospital Outcomes in Patients With Atrial Fibrillation and Coronary Artery Diseases","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}